Emerging Phage Resistance in
Anti-Bacterial Agents
/ pharmacology
Bacteriophages
/ genetics
Biofilms
/ growth & development
Drug Resistance, Microbial
/ genetics
Humans
Phage Therapy
/ methods
Phagocytosis
/ genetics
Phenotype
Pseudomonas Infections
/ microbiology
Pseudomonas Phages
/ genetics
Pseudomonas aeruginosa
/ genetics
Virulence
Pseudomonas aeruginosa
biofilm
heterogeneity
phage-resistant mutants
virulence
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
10 07 2021
10 07 2021
Historique:
received:
12
06
2021
revised:
05
07
2021
accepted:
07
07
2021
entrez:
10
8
2021
pubmed:
11
8
2021
medline:
18
9
2021
Statut:
epublish
Résumé
Bacterial surface structures of a proteinic nature and glycoconjugates contribute to biofilm formation and provide shields to host defense mechanisms (e.g., the complement system and phagocytosis). A loss or alteration of these molecules, leading to phage resistance, could result in fewer virulent bacteria. In this study, we evaluate the biology and phenotype changes in
Identifiants
pubmed: 34372538
pii: v13071332
doi: 10.3390/v13071332
pmc: PMC8310095
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Microb Pathog. 2020 Sep;146:104249
pubmed: 32418905
Sci Rep. 2015 Jun 05;5:10932
pubmed: 26047320
Annu Rev Microbiol. 2010;64:357-72
pubmed: 20528688
Anal Biochem. 1982 Jan 1;119(1):115-9
pubmed: 6176137
Microbiology (Reading). 2015 Oct;161(10):1961-1977
pubmed: 26253522
Sci Rep. 2017 Nov 24;7(1):16302
pubmed: 29176754
Viruses. 2017 Oct 27;9(11):
pubmed: 29077053
Front Microbiol. 2017 Jun 30;8:1229
pubmed: 28713356
Infect Immun. 1998 Sep;66(9):4244-53
pubmed: 9712774
mBio. 2012 Mar 13;3(2):
pubmed: 22415004
Antimicrob Agents Chemother. 2018 May 25;62(6):
pubmed: 29555626
Sci Rep. 2019 Jul 5;9(1):9777
pubmed: 31278366
Appl Environ Microbiol. 2013 May;79(9):2862-71
pubmed: 23435883
Anal Biochem. 1999 Feb 1;267(1):161-8
pubmed: 9918668
J Infect Dis. 2017 Mar 1;215(5):703-712
pubmed: 28007922
Curr Opin Microbiol. 2011 Oct;14(5):593-8
pubmed: 21937262
Clin Infect Dis. 2006 Sep 1;43 Suppl 2:S49-56
pubmed: 16894515
PLoS One. 2012;7(10):e46718
pubmed: 23056420
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30082283
PLoS One. 2015 May 21;10(5):e0127603
pubmed: 25996839
Clin Microbiol Rev. 2020 May 13;33(3):
pubmed: 32404435
Environ Microbiol. 2021 Mar 22;:
pubmed: 33754440
Annu Rev Microbiol. 2002;56:289-314
pubmed: 12142488
Nat Rev Microbiol. 2012 Dec;10(12):841-51
pubmed: 23147702
J Vis Exp. 2011 Jan 30;(47):
pubmed: 21307833
J Immunol. 1984 Jan;132(1):376-85
pubmed: 6197450
Nucleic Acids Res. 2018 May 18;46(9):4505-4514
pubmed: 29514250
J Bacteriol. 1990 Jul;172(7):3590-9
pubmed: 2163382
Antibiotics (Basel). 2021 Jan 04;10(1):
pubmed: 33406652
Front Cell Infect Microbiol. 2017 Feb 15;7:39
pubmed: 28261568
Microbiology (Reading). 2016 May;162(5):748-763
pubmed: 26921273
FEMS Microbiol Rev. 2014 Sep;38(5):916-31
pubmed: 24617569
PLoS Biol. 2018 Oct 3;16(10):e2006057
pubmed: 30281587
Nat Rev Microbiol. 2010 May;8(5):317-27
pubmed: 20348932
Drug Metab Dispos. 2012 Oct;40(10):1953-65
pubmed: 22798553
PLoS One. 2012;7(4):e35648
pubmed: 22558188
Cell Host Microbe. 2017 Jul 12;22(1):38-47.e4
pubmed: 28704651
Nature. 2000 Sep 7;407(6800):98-102
pubmed: 10993081
Microbiology (Reading). 1998 Aug;144 ( Pt 8):2225-2232
pubmed: 9720044
Methods Enzymol. 1994;235:554-62
pubmed: 8057926
Nat Rev Microbiol. 2017 Sep;15(9):517-530
pubmed: 28649138